Trial intelligence / Profile preview

BIBR 277 in Hypertension with Nephropathy

NCT02187484Phase 2Completed

Sponsor
Boehringer Ingelheim
Start
Aug 1998
Primary completion
Aug 1999
Modality
Small Molecules
01

Overview

A Phase 2 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Aug 1998; status: completed.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02187484.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02187484.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call